Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

OBJECTIVES: To compare risks for COVID-19-related outcomes in inflammatory joint diseases (IJDs) and across disease-modifying antirheumatic drugs (DMARDs) during the first two waves of the pandemic and to assess effects of the pandemic on rheumatology care provision. METHODS: Through nationwide mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Bower, Hannah, Frisell, Thomas, di Giuseppe, Daniela, Delcoigne, Bénédicte, Alenius, Gerd-Marie, Baecklund, Eva, Chatzidionysiou, Katerina, Feltelius, Nils, Forsblad-d'Elia, Helena, Kastbom, Alf, Klareskog, Lars, Lindqvist, Elisabet, Lindström, Ulf, Turesson, Carl, Sjöwall, Christopher, Askling, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655349/
https://www.ncbi.nlm.nih.gov/pubmed/34880127
http://dx.doi.org/10.1136/rmdopen-2021-001987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655349/
https://www.ncbi.nlm.nih.gov/pubmed/34880127
http://dx.doi.org/10.1136/rmdopen-2021-001987

Ejemplares similares